evoke trial News

Latest Articles

• Two Major Phase 3 Trials Confirm Oral Semaglutide Fails to Slow Cognitive Decline in Early Alzheimer’s Patients

  Published: Mar 23, 2026

  Section: Health

  Results from the global "evoke" and "evoke+" clinical trials published in The Lancet show that oral semaglutide does not meaningfully delay the progression of early-stage Alzheimer...